Omnicell (OMCL Quick QuoteOMCL - Free Report) reported $307.85 million in revenue for the quarter ended September 2026, representing a year-over-year decline of 0.9%. EPS of $0.58 for the same period compares to $0.51 a year ago.

The reported revenue represents a surprise of +1.42% over the Zacks Consensus Estimate of $303.53 million. With the consensus EPS estimate being $0.42, the EPS surprise was +38.1%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Omnicell performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Product: $173.05 million versus the two-analyst average estimate of $170.05 million. The reported number represents a year-over-year change of -2.5%.
• Revenues- Service: $134.8 million versus the two-analyst average estimate of $133.48 million. The reported number represents a year-over-year change of +1.3%.
• Gross Profit- Services- GAAP: $63 million versus the two-analyst average estimate of $59.2 million.
• Gross Profit- Product- GAAP: $74.83 million compared to the $68.81 million average estimate based on two analysts.

View all Key Company Metrics for Omnicell here>>>

Shares of Omnicell have returned +5.6% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.